Screening for malignant melanoma-a critical assessment in historical perspective
- PMID: 29785325
- PMCID: PMC5955075
- DOI: 10.5826/dpc.0802a06
Screening for malignant melanoma-a critical assessment in historical perspective
Abstract
Screening for melanoma has been advocated for many years because early detection and excision have been regarded as the most important measure to lower mortality from that neoplasm. In the past decade, concern has been raised by epidemiologists that screening might result in excision chiefly of "inconsequential cancer," i.e., melanomas that would never have progressed into life-threatening tumors, a phenomenon referred to by the misleading term "overdiagnosis." Without any firm evidence, that speculation has been embraced worldwide, and incipient melanomas have been trivialized. At the same time, efforts at early detection of melanoma have continued and have resulted in biopsy of pigmented lesions at a progressively earlier stage, such as lesions with a diameter of only 2, 3, or 4 mm. Those tiny lesions often lack sufficient criteria for clinical and histopathologic diagnosis, the result being true overdiagnoses, i.e., misdiagnoses of melanocytic nevi as melanoma. This is especially true if available criteria for histopathologic diagnosis are diminuished even further by incomplete excision of lesions. The reliability of histopathologic diagnosis is far higher in excisional biopsies of lesions that were given some more time to develop changes that make them recognizable. Biopsy of pigmented lesions with a diameter of 6 mm has been found to result in a far higher yield of melanomas. In addition to better clinical judgment, slight postponement of biopsies bears the promise of substantial improvement of the reliability of histopathologic diagnosis, and of alleviating true overdiagnoses.
Keywords: melanoma; overdiagnosis; screening.
Conflict of interest statement
Competing interests: The authors have no conflicts of interest to disclose.
Figures









Similar articles
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
The 'epidemic' of melanoma between under- and overdiagnosis.J Cutan Pathol. 2012 Jan;39(1):9-16. doi: 10.1111/j.1600-0560.2011.01831.x. J Cutan Pathol. 2012. PMID: 22211330 Review.
-
Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.Med Clin North Am. 1986 Jan;70(1):3-37. doi: 10.1016/s0025-7125(16)30966-x. Med Clin North Am. 1986. PMID: 3510347 Review.
-
Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.JAMA Dermatol. 2019 May 1;155(5):578-584. doi: 10.1001/jamadermatol.2018.5926. JAMA Dermatol. 2019. PMID: 30865233 Free PMC article.
-
[Clinical and histopathologic analyses of pigmented macular lesions on the soles of Japanese--proposal of a clinical guideline for detection of early malignant melanoma on the sole].Nihon Hifuka Gakkai Zasshi. 1989 Feb;99(2):117-28. Nihon Hifuka Gakkai Zasshi. 1989. PMID: 2746966 Japanese.
Cited by
-
Second Primary Cancers in Melanoma Patients Critically Shorten Survival.Clin Epidemiol. 2020 Jan 23;12:105-112. doi: 10.2147/CLEP.S230149. eCollection 2020. Clin Epidemiol. 2020. PMID: 32158273 Free PMC article.
-
Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions.Diagnostics (Basel). 2019 Aug 25;9(3):103. doi: 10.3390/diagnostics9030103. Diagnostics (Basel). 2019. PMID: 31450697 Free PMC article.
-
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.Front Immunol. 2021 Jun 4;12:680407. doi: 10.3389/fimmu.2021.680407. eCollection 2021. Front Immunol. 2021. PMID: 34149718 Free PMC article. Review.
-
Photoacoustic imaging for cutaneous melanoma assessment: a comprehensive review.J Biomed Opt. 2024 Jan;29(Suppl 1):S11518. doi: 10.1117/1.JBO.29.S1.S11518. Epub 2024 Jan 12. J Biomed Opt. 2024. PMID: 38223680 Free PMC article. Review.
-
Pigmented Lesion Assay for Suspected Melanoma Lesions: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 Jun 4;21(5):1-81. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34188732 Free PMC article.
References
-
- Kaposi M. Bösartige Neubildungen. In: Virchow R, editor. Handbuch der speziellen Pathologie und Therapie. VIII. Erlangen; Enke: 1872. p. 466. (Hrsg.)
-
- Melanom Miescher G. In: Handbuch der Haut- und Geschlechtskrankheiten, Zwölfter Band, dritter Teil. Jadassohn J, editor. Berlin: Julius Springer; 1933. p. 1118. (Geschwülste der Haut II). (Hrsg.)
-
- Delacrétaz J, Jaeger H. Die Melanome (Die malignen Melanome) In: Gottron HA, Schönfeld W, editors. Dermatologie und Venerologie. IV. Stuttgart: Georg Thieme; 1960. p. 619.
-
- Allen AC, Spitz S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6:1–45. - PubMed
-
- Lane N, Lattes R, Malm J. Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults. Cancer. 1958;11:1025–1043. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous